X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29495) 29495
Book Chapter (137) 137
Book / eBook (93) 93
Magazine Article (88) 88
Publication (19) 19
Conference Proceeding (10) 10
Web Resource (10) 10
Dissertation (9) 9
Newsletter (9) 9
Newspaper Article (8) 8
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27651) 27651
science & technology (17993) 17993
life sciences & biomedicine (17475) 17475
male (16515) 16515
female (13796) 13796
aged (11844) 11844
middle aged (11417) 11417
urinary bladder neoplasms - pathology (10164) 10164
bladder cancer (7751) 7751
urinary bladder neoplasms - drug therapy (7492) 7492
oncology (7200) 7200
urology & nephrology (7044) 7044
adult (6217) 6217
urinary bladder neoplasms - therapy (5890) 5890
urinary bladder neoplasms - surgery (5692) 5692
cancer (5336) 5336
aged, 80 and over (4741) 4741
prognosis (3830) 3830
treatment outcome (3639) 3639
abridged index medicus (3543) 3543
neoplasm staging (3262) 3262
animals (3104) 3104
carcinoma, transitional cell - pathology (3048) 3048
urinary bladder neoplasms - mortality (3009) 3009
urology (2995) 2995
retrospective studies (2896) 2896
follow-up studies (2811) 2811
care and treatment (2802) 2802
combined modality therapy (2749) 2749
bladder (2694) 2694
cystectomy (2637) 2637
neoplasm invasiveness (2571) 2571
urinary bladder neoplasms - diagnosis (2537) 2537
urinary bladder neoplasms - radiotherapy (2537) 2537
urinary bladder neoplasms - genetics (2464) 2464
administration, intravesical (2425) 2425
carcinoma, transitional cell - drug therapy (2417) 2417
urinary bladder neoplasms - metabolism (2275) 2275
antineoplastic combined chemotherapy protocols - therapeutic use (2102) 2102
urinary bladder (2072) 2072
risk factors (2071) 2071
tumors (2067) 2067
research (2066) 2066
chemotherapy (2007) 2007
analysis (1985) 1985
time factors (1950) 1950
cell line, tumor (1917) 1917
carcinoma, transitional cell - surgery (1882) 1882
radiotherapy (1729) 1729
carcinoma, transitional cell - therapy (1721) 1721
surgery (1717) 1717
health aspects (1631) 1631
radiotherapy dosage (1612) 1612
mice (1603) 1603
radiology, nuclear medicine & medical imaging (1596) 1596
survival rate (1541) 1541
urinary bladder neoplasms (1537) 1537
antineoplastic agents - therapeutic use (1520) 1520
medicine & public health (1518) 1518
bcg vaccine - therapeutic use (1475) 1475
prostate cancer (1409) 1409
prospective studies (1379) 1379
urinary bladder - pathology (1369) 1369
cystectomy - methods (1339) 1339
immunohistochemistry (1334) 1334
carcinoma (1257) 1257
disease-free survival (1253) 1253
cisplatin - administration & dosage (1218) 1218
patients (1216) 1216
prostatic neoplasms - radiotherapy (1215) 1215
carcinoma, transitional cell - mortality (1212) 1212
disease progression (1208) 1208
diagnosis (1185) 1185
metastasis (1185) 1185
pathology (1174) 1174
neoplasm recurrence, local (1160) 1160
bcg vaccine - administration & dosage (1133) 1133
chemotherapy, adjuvant (1082) 1082
survival analysis (1043) 1043
urinary bladder - radiation effects (1028) 1028
development and progression (1024) 1024
immunotherapy (1021) 1021
hematology, oncology and palliative medicine (1002) 1002
urinary bladder neoplasms - immunology (972) 972
medicine (963) 963
urothelial carcinoma (960) 960
apoptosis (943) 943
urinary bladder neoplasms - epidemiology (941) 941
doxorubicin - administration & dosage (910) 910
neoplasm metastasis (897) 897
urinary bladder - surgery (888) 888
oncology, experimental (884) 884
prostatic neoplasms - surgery (874) 874
antineoplastic agents - administration & dosage (869) 869
cystoscopy (858) 858
tomography, x-ray computed (850) 850
urinary bladder neoplasms - complications (850) 850
prostate (846) 846
prostatic neoplasms - pathology (836) 836
research article (836) 836
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (14) 14
Online Resources - Online (12) 12
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
St. Michael's Hospital - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
Toronto East General Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (26522) 26522
Japanese (1197) 1197
German (935) 935
French (798) 798
Spanish (473) 473
Russian (323) 323
Italian (276) 276
Chinese (174) 174
Polish (69) 69
Portuguese (58) 58
Hungarian (38) 38
Danish (32) 32
Czech (28) 28
Bulgarian (27) 27
Dutch (25) 25
Hebrew (16) 16
Norwegian (15) 15
Romanian (14) 14
Swedish (14) 14
Turkish (10) 10
Serbian (9) 9
Finnish (8) 8
Slovak (8) 8
Croatian (7) 7
Lithuanian (4) 4
Bosnian (3) 3
Afrikaans (2) 2
Arabic (1) 1
Greek (1) 1
Icelandic (1) 1
Korean (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European urology, ISSN 0302-2838, 10/2014, Volume 66, Issue 4, pp. 677 - 688
...–muscle-invasive bladder cancer (NMIBC) is unknown. Objectives To compare clinical efficacy, immunogenicity, and genetics of BCG Connaught and Tice... 
Urology | BCG Tice | Intravesical drug administration | Flow cytometry | Urinary bladder neoplasms | BCG Connaught | Immunotherapy | Animal | Models | BCG vaccine | Randomized controlled trial | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Carcinoma, Transitional Cell - mortality | Immunotherapy - methods | Prospective Studies | Humans | Middle Aged | BCG Vaccine - classification | Male | Neoplasm Recurrence, Local - mortality | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Statistics, Nonparametric | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Female | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Risk Assessment | Mice, Inbred C57BL | Kaplan-Meier Estimate | Urinary Bladder Neoplasms - drug therapy | Disease-Free Survival | Animals | Carcinoma, Transitional Cell - pathology | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Mice | Administration, Intravesical | BCG Vaccine - administration & dosage | Index Medicus | BCG Vaccine/classification | Carcinoma, Transitional Cell/pathology | Immunotherapy/methods | Life Sciences | Carcinoma, Transitional Cell/drug therapy | Immunology | Carcinoma, Transitional Cell/mortality | Neoplasm Recurrence, Local/mortality | Urinary Bladder Neoplasms/drug therapy | Neoplasm Recurrence, Local/pathology | Urinary Bladder Neoplasms/pathology | BCG Vaccine/administration & dosage | Urinary Bladder Neoplasms/mortality
Journal Article
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 11/2016, Volume 68, pp. 156 - 162
...) durvalumab in combination with radiotherapy (RT) in an expansion cohort of patients included in a phase 1/2 trial at our institution... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis | Index Medicus
Journal Article